These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35247719)

  • 1. Recent update on application of dihydromyricetin in metabolic related diseases.
    Wang Y; Wang J; Xiang H; Ding P; Wu T; Ji G
    Biomed Pharmacother; 2022 Apr; 148():112771. PubMed ID: 35247719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dihydromyricetin ameliorates the oxidative stress response induced by methylglyoxal via the AMPK/GLUT4 signaling pathway in PC12 cells.
    Jiang B; Le L; Pan H; Hu K; Xu L; Xiao P
    Brain Res Bull; 2014 Oct; 109():117-26. PubMed ID: 25451453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dihydromyricetin protects HUVECs of oxidative damage induced by sodium nitroprusside through activating PI3K/Akt/FoxO3a signalling pathway.
    Zhang X; Wang L; Peng L; Tian X; Qiu X; Cao H; Yang Q; Liao R; Yan F
    J Cell Mol Med; 2019 Jul; 23(7):4829-4838. PubMed ID: 31111658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolomics reveals the protective of Dihydromyricetin on glucose homeostasis by enhancing insulin sensitivity.
    Le L; Jiang B; Wan W; Zhai W; Xu L; Hu K; Xiao P
    Sci Rep; 2016 Oct; 6():36184. PubMed ID: 27796348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semaphoring 4D is required for the induction of antioxidant stress and anti-inflammatory effects of dihydromyricetin in colon cancer.
    Liang J; Wu J; Wang F; Zhang P; Zhang X
    Int Immunopharmacol; 2019 Feb; 67():220-230. PubMed ID: 30562683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dihydromyricetin ameliorates oleic acid-induced lipid accumulation in L02 and HepG2 cells by inhibiting lipogenesis and oxidative stress.
    Xie C; Chen Z; Zhang C; Xu X; Jin J; Zhan W; Han T; Wang J
    Life Sci; 2016 Jul; 157():131-139. PubMed ID: 27265384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research progress of dihydromyricetin in the treatment of diabetes mellitus.
    Wang Z; Cao Z; Yue Z; Yang Z
    Front Endocrinol (Lausanne); 2023; 14():1216907. PubMed ID: 37732125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dihydromyricetin improves LPS-induced sickness and depressive-like behaviors in mice by inhibiting the TLR4/Akt/HIF1a/NLRP3 pathway.
    Wei Y; Hu Y; Qi K; Li Y; Chen J; Wang R
    Behav Brain Res; 2022 Apr; 423():113775. PubMed ID: 35101458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dihydromyricetin increases endothelial nitric oxide production and inhibits atherosclerosis through microRNA-21 in apolipoprotein E-deficient mice.
    Yang D; Yang Z; Chen L; Kuang D; Zou Y; Li J; Deng X; Luo S; Luo J; He J; Yan M; He G; Deng Y; Li R; Yuan Q; Zhou Y; Jiang P; Tan S
    J Cell Mol Med; 2020 May; 24(10):5911-5925. PubMed ID: 32301289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dihydromyricetin ameliorates atherosclerosis in LDL receptor deficient mice.
    Liu TT; Zeng Y; Tang K; Chen X; Zhang W; Xu XL
    Atherosclerosis; 2017 Jul; 262():39-50. PubMed ID: 28500865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of dihydromyricetin on hyperthermia-induced apoptosis in human myelomonocytic lymphoma cells.
    Feng QW; Cui ZG; Jin YJ; Sun L; Li ML; Zakki SA; Zhou DJ; Inadera H
    Apoptosis; 2019 Apr; 24(3-4):290-300. PubMed ID: 30684145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Update on the Pharmacological Effects and Mechanisms of Dihydromyricetin.
    Zhang J; Chen Y; Luo H; Sun L; Xu M; Yu J; Zhou Q; Meng G; Yang S
    Front Pharmacol; 2018; 9():1204. PubMed ID: 30410442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multitarget and promising role of dihydromyricetin in the treatment of metabolic diseases.
    Tong H; Zhang X; Tan L; Jin R; Huang S; Li X
    Eur J Pharmacol; 2020 Mar; 870():172888. PubMed ID: 31866404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cardioprotective effect of dihydromyricetin prevents ischemia-reperfusion-induced apoptosis in vivo and in vitro via the PI3K/Akt and HIF-1α signaling pathways.
    Liu S; Ai Q; Feng K; Li Y; Liu X
    Apoptosis; 2016 Dec; 21(12):1366-1385. PubMed ID: 27738772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydromyricetin attenuates D-galactose-induced brain aging of mice via inhibiting oxidative stress and neuroinflammation.
    Qian J; Wang X; Cao J; Zhang W; Lu C; Chen X
    Neurosci Lett; 2021 Jun; 756():135963. PubMed ID: 34022267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydromyricetin relieves rheumatoid arthritis symptoms and suppresses expression of pro-inflammatory cytokines via the activation of Nrf2 pathway in rheumatoid arthritis model.
    Chu J; Wang X; Bi H; Li L; Ren M; Wang J
    Int Immunopharmacol; 2018 Jun; 59():174-180. PubMed ID: 29656207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydromyricetin protects human umbilical vein endothelial cells from injury through ERK and Akt mediated Nrf2/HO-1 signaling pathway.
    Luo Y; Lu S; Dong X; Xu L; Sun G; Sun X
    Apoptosis; 2017 Aug; 22(8):1013-1024. PubMed ID: 28612103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dihydromyricetin resists inflammation-induced muscle atrophy via ryanodine receptor-CaMKK-AMPK signal pathway.
    Hou L; Jiang F; Huang B; Zheng W; Jiang Y; Cai G; Liu D; Hu CY; Wang C
    J Cell Mol Med; 2021 Nov; 25(21):9953-9971. PubMed ID: 34676967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Protective effect and mechanisms of dihydromyricetin on PC12 cells induced by oxidative injury].
    Liao SF; Wang HT; Yan FX; Zheng YX; Zeng ZW; Zheng WH
    Zhong Yao Cai; 2014 Jun; 37(6):1014-20. PubMed ID: 25470969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dihydromyricetin improves skeletal muscle insulin sensitivity by inducing autophagy via the AMPK-PGC-1α-Sirt3 signaling pathway.
    Shi L; Zhang T; Zhou Y; Zeng X; Ran L; Zhang Q; Zhu J; Mi M
    Endocrine; 2015 Nov; 50(2):378-89. PubMed ID: 25896550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.